Accéder au contenu
Merck

Mechanistic studies of the inactivation of tyrosinase by resorcinol.

Bioorganic & medicinal chemistry (2013-01-29)
Michael R L Stratford, Christopher A Ramsden, Patrick A Riley
RÉSUMÉ

The inactivation of tyrosinase by resorcinol (1,3-dihydroxybenzene) and seventeen simple derivatives has been investigated using combined spectrophotometry and oximetry together with hplc/ms examination of the oxidation products. The results are consistent with a Quintox mechanism, analogous to that proposed for catechol inactivation of tyrosinase, in which the resorcinol substrate is oxidised via the monooxygenase route leading to a hydroxy intermediate that undergoes deprotonation and results in irreversible elimination of Cu(0) from the active site. Hplc/ms evidence for formation of the resorcinol monooxygenase product (3-hydroxy-ortho-quinone) is presented and the relationship between the ring position of simple resorcinol substituents (H, Me, F, Cl) and tyrosinase inactivation is rationalised.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Resorcinol, ACS reagent, ≥99.0%
Sigma-Aldrich
1,2-Dihydroxybenzene, ReagentPlus®, ≥99%
Sigma-Aldrich
Resorcinol, ≥98%, FG
Sigma-Aldrich
Pyrocatechol, ≥99%
Sigma-Aldrich
Resorcinol, ReagentPlus®, 99%
Sigma-Aldrich
Resorcinol, meets analytical specification of Ph. Eur., BP, 98.5-100.5% (calc. to the dried substance)
Sigma-Aldrich
Resorcinol, BioXtra, ≥99%
Sigma-Aldrich
Pyrocatechol, purified by sublimation, ≥99.5%
Supelco
Resorcinol, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland